Shire gets approvable letter for adult ADHD drug

British drugmaker Shire Plc said on Monday it had received an "approvable letter" from U.S. regulators for SPD465, its experimental treatment for attention deficit hyperactivity disorder (ADHD) in adults.

Source: Reuters